Maria Teresa Sanz Martinez

Institutions of which they are part

Predoctoral researcher
Translational Immunology

Vall Hebron Institut de Recerca

Doctor
Immunology

Cross-departmental services

Maria Teresa Sanz Martinez

Institutions of which they are part

Predoctoral researcher
Translational Immunology

Vall Hebron Institut de Recerca

Doctor
Immunology

Cross-departmental services

Projects

CARACTERIZACIÓNDE LA FARMACOCINÈTICA DE RITUXIMAB EN PACIENTS AMB MALALTIES RENALS AMB AFECTACIÓ GLOMERULAR

IP: Maria Larrosa Garcia
Collaborators: Mónica Martínez Gallo, J. Bruno Montoro Ronsano, Maria Queralt Gorgas Torner, Irene Agraz Pamplona, Carla Alonso Martinez, Maria Teresa Sanz Martinez, Sonia García García
Funding agency: Societat Catalana de Farmàcia Clínica
Funding: 12000
Reference: SCFC/JOAQUIM.BONAL/2022/LARROSA
Duration: 01/09/2022 - 30/08/2024

Related news

New method to improve diagnosis and classification of patients with scleroderma

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

Vall d’Hebron confirms the utility of the Ex Vivo C5b-9 deposition test

A study from the Vall d’Hebron Campus demonstrates that the Ex Vivo C5b-9 deposition test is useful for monitoring the activity of the complement system (CS) in patients with aHUS or transplant-associated TMA.

A study describes a genetic mechanism related to a type of immunodeficiency in women

The results show that, in some patients with mutations in the X chromosome, the healthy gene is inactivated and the mutated gene manifests itself, which favors the onset of the disease.